The groundbreaking rise of Viagra has consistently remained a example of pharmaceutical success, however its legacy within the broader industry now raises questions about future returns . Copycat versions are undercutting market share, leading to worries that investing in companies heavily reliant to Viagra's once-dominant standing could be a specu